Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients is a research paper published in The Journal of Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 54 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UL1TR002525
National Institutes of Health
Grant: UL1TR002535-03S3
National Institutes of Health
Grant: UL1TR002535-04S2
NCATS NIH HHS
Grant: UL1 TR002535
National Institutes of Health
Grant: 3UL1TR002535-03S1
NIH Prior Approval Process Professional
National Center for Advancing Translational Sciences
FWCI
5.22
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 5 of Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients
Additional file 5 of Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients